| TRADING CENTER |
54.09+1.25 / +2.37%
Biogen Idec Inc (NASDAQ GS:BIIB)
52.84-1.25 / -2.31
After hours quote
Prev. Close:
52.84
Open:
53.88
High:
54.88
Low:
53.33
Volume:
2,965,000
Volume Avg.:
2,935,300
52wk Range:
41.75 - 55.37
Market Cap (mil):
15,642.77
P/E Ratio:
16.15
Dividend Yield:
N/A
| Biogen Beats & Guides Higher - Analyst Blog - Zacks.com | |
| Biogen 4th-qtr profit up, outlook tops estimates - Reuters | |
| Company News for February 9, 2010 - Corporate Summary - Zacks.com | |
| Biogen 4th-qtr profit up; outlook tops estimates - Reuters | |
| Greece Debt: Tuesday's Headlines - at TheStreet.com | |
| Biogen Idec Offers 2010 Guidance: BioBuzz - at TheStreet.com | |
| Stocks in the News: Toyota, Electronic Arts, Coca-Cola - DailyFinance | |
| Biogen 4th-qtr profit up; price rises help sales - Reuters | |
| Biogen Idec Reports Full Year and Fourth Quarter 2009 Results - Business Wire | |
| US warns of risk rise with more Tysabri infusions - Reuters | |
| A Drugless Drugmaker IPO! - MotleyFool.com | |
| New Zacks.com Research Report for Biogen Idec Inc.(BIIB) ($) - Zacks.com | |
| Pfizer's Hedge Pays Off - MotleyFool.com | |
| Wake Up! You Still Have to Pay Attention - MotleyFool.com | |
| Icahn Back to Batter Biogen - MotleyFool.com |
| Last trade | Change/%change | P/E ratio | ||
|---|---|---|---|---|
| AMGN | Amgen Inc | 57.21 | -0.25 / -0.44% | 11.65 |
| GILD | Gilead Sciences Inc | 46.30 | 0.21 / 0.46% | 15.13 |
| CELG | Celgene Corporation | 55.50 | 0.73 / 1.33% | 26.68 |
Short Interest Date:
Jan 15 2010
Short Interest Shares:
8,004,263
Short Interest Ratio:
2.8
Float:
288,259,621
Short Interest as a % of Float:
3.1%
Average Daily Volume:
2,843,500
Outstanding Shares:
289,198,517
Biogen Idec Inc. is a global biotechnology company that creates new standards of care in therapeutic areas of high unmet medical needs. The company's business strategy is focused on discovering and developing first-in-class or best-in-class products that it could deliver to specialty markets ... (more)
| 2008 Revenue: | $4.1 B | Headquarters: Cambridge, MA |
| Employees: | 4,700 | CEO: James C. Mullen |
| Net Income: | $783.2 M | Industry: Biotechnology |
| Market Cap: | $15.3 B | Website: www.biogenidec.com |
| Symbol | Price | Change/%Change | Prev. close | High | Low | Last Update | More Info |
|---|---|---|---|---|---|---|---|
| BIIB | 54.09 | +1.25 / +2.37% | 52.84 | 54.88 | 53.33 | Profile Chart News |
© 2010 Cable News Network. A Time Warner Company. All Rights Reserved.
Terms under which this service is provided to you. Privacy Policy. Advertising Practices.
Live Quotes automatically refresh, but individual equities are delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges. Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET.
* : Time reflects local markets trading time. † - Intraday data delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges. Disclaimer
* : Time reflects local markets trading time. † - Intraday data delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges. Disclaimer
| Copyright © 2010 BigCharts.com Inc. All rights reserved. Please see our Terms of Use. MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc. Intraday data provided by Interactive Data Real-Time Services and subject to the Terms of Use. Intraday data is at least 20-minutes delayed. All times are ET. Historical, current end-of-day data, and splits data provided by Interactive Data Pricing and Reference Data. Fundamental data provided by Morningstar, Inc.. SEC Filings data provided by Edgar Online Inc.. Earnings data provided by FactSet CallStreet, LLC. |
